You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《全日总结》恒指跌191点 汇控渣打受压 物管股涨
阿思达克 12-21 16:37
美国国会就9,000亿美元抗疫援助方案达成协议,本周港股仅三日全交易日。恒指今早低开75点後,早段曾最多跌223点,其後反覆走低,全日跌191点或0.7%,报26,306点;国指跌81点或0.8%,报10,401点;恒生科技指数跌93点或1.1%,报8,159点。大市全日成交总额1,438.84亿元,沪、深港通南下交易全日录得分别流出5.13亿及流入32.98亿元人民币。

中央经济工作会议称,金融创新必须在审慎监管的前提下进行,多个主流平台的线上存款产品先後下架。科技股个别发展,腾讯(00700.HK)全日跌1.4%报572元,阿里巴巴(09988.HK)跌2.2%报250元。手机设备股舜宇(02382.HK)及瑞声(02018.HK)分别跌1.2%及2.1%。

小米(01810.HK)一度创新高,午後升幅回落,全日升1.7%报29.3元;美团(03690.HK)无升跌报278.4元。

中芯(00981.HK)遭美列入实体名单,对个别产品有不利影响,全日跌3.6%收报19.14元;国药(01099.HK)附属中科器遭美国实施出口限制措施,跌1.1%报18.5元。

英国疫情转差,汇控(00005.HK)跌4%报39.5元,渣打(02888.HK)亦跌4.5%报47元。友邦(01299.HK)升0.4%报89.85元,中移动(00941.HK)跌3.1%报44.15元,联通(00762.HK)跌2.6%报4.44元。中资金融股建行(00939.HK)及工行(01398.HK)分别跌1.7%及1.3%,中国平安(02318.HK)跌2.1%。

其他蓝筹股方面,港交所(00388.HK)创新高,升2.3%报403元。药明生物(02269.HK)升3.7%,为表现最佳蓝筹股,安踏(02020.HK)升2.8%;中海外(00688.HK)跌2.7%,新世界(00017.HK)亦跌2.4%。

物管股逆市造好,华润万象(01209.HK)急升11.7%,碧桂园服务(06098.HK)升10%,时代邻里(09928.HK)、宝龙商业(09909.HK)、合景悠活(03913.HK)及新城悦服(01755.HK)升7.5%至8.8%。

「半新股」获追捧,上周五挂牌的Vesync(02148.HK)飙29%收报11.36元;泡泡玛特(09992.HK)升14%,报87.75元;京东健康(06618.HK)升12.2%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account